Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Grastofil (filgrastim)
pCPA File Number:
20898
Negotiation Status:
Concluded with an LOI
Indication(s):
Prevention or treatment of neutropenia in various indications
Sponsor/Manufacturer:
ApoPharm Inc.
CADTH Project Number:
SE0446-000
pCPA Engagement Letter Issued:
2016-06-15
Negotiation Process Concluded:
2016-12-12